Why do GWAS studies require a large sample size?

Why do GWAS studies require a large sample size?

Genome-wide association studies require much larger sample sizes to achieve an adequate statistical power. We estimated the statistical power with increasing numbers of markers analyzed and compared the sample sizes that were required in case-control studies and case-parent studies.

How many samples are needed for population genetics?

For population genetic studies based on microsatellites, ususally it is recommended to sample at least 30 individuals per population to have enough power.

What do genome-wide association studies require?

A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease.

What kind of disease are studied using genome-wide association studies?

“Genome-wide association studies have helped identify SNPs associated with conditions such as type 2 diabetes, Alzheimer’s disease, Parkinson’s disease and Crohn’s disease.

How big should the sample size be for genome wide association studies?

For binary traits, simulations assumed a disease prevalence of 25%, a relative risk of 3 and a sample size of only 75 cases and 75 controls. These parameter settings are not realistic for genome-wide association studies or useful when designing new studies.

How is power determined in a genome wide association study?

Although coverage is straightforward to estimate, power is a complicated function of the set of SNPs on the chip, effect size, and sample size, and can only be assessed by simulation.

How are genome wide association studies revolutionizing medicine?

Genome-wide association studies are revolutionizing the search for the genes underlying human complex diseases. The main decisions to be made at the design stage of these studies are the choice of the commercial genotyping chip to be used and the numbers of case and control samples to be genotyped.

Is there a genome wide association study for MDD?

However, no significant MDD-associated variant has been discovered even in a large genome-wide association study (GWAS) with around 9,500 cases by the Psychiatric Genomics Consortium (PGC) ( Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, 2013; Levinson et al., 2014 ).